Is accelerated partner therapy a feasible and acceptable strategy for rapid partner notification in the UK?: a qualitative study of genitourinary medicine clinic attenders.
Partner notification (PN) in the UK is of limited effectiveness. Expedited partner therapy improves PN outcomes but does not comply with existing UK professional guidance. We developed two new strategies, known as accelerated partner therapy (APT), based on elements of PN practice for which there is evidence of efficacy, and which conform to UK prescribing guidance. We explored the acceptability and feasibility of these models qualitatively in genitourinary medicine clinic attenders. Both strategies were viewed favourably. Preference was influenced by age, relationship type, whether participants were delivering or receiving APT and whether the sex partner was aware of the participant's clinic visit. APT provides a new approach to PN, which has strong patient support and complies with existing UK regulations. The complex factors that influence patients' choice of PN method suggest that provision of a range of PN options including APT may be central to improving the effectiveness of PN in the UK.
Sutcliffe
L
L
Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, London, UK. l.j.sutcliffe@qmul.ac.uk
Brook
M G
MG
Chapman
J L
JL
Cassell
J M
JM
Estcourt
C S
CS
D000328:Adult; D016358:Contact Tracing; D005260:Female; D052776:Female Urogenital Diseases / Q000628:therapy*; D006801:Humans; D008297:Male; D052801:Male Urogenital Diseases / Q000628:therapy*; D012747:Sexual Partners; D012749:Sexually Transmitted Diseases / Q000517:prevention & control*; D006113:United Kingdom